C Nieder, AL Grosu, LE Gaspar - Radiation Oncology, 2014 - Springer
In many patients with brain metastases, the primary therapeutic aim is symptom palliation and maintenance of neurologic function, but in a subgroup, long-term survival is possible …
Q Song, J Ruiz, F Xing, HW Lo, L Craddock… - Communications …, 2023 - nature.com
Brain metastases is the most common intracranial tumor and account for approximately 20% of all systematic cancer cases. It is a leading cause of death in advanced-stage cancer …
Purpose: Stereotactic radiosurgery (SRS) is a common treatment used in patients with brain metastases and is associated with high rates of local control, however, at the risk of radiation …
M Farris, ER McTyre, CK Cramer, R Hughes… - International Journal of …, 2017 - Elsevier
Purpose Prior statistical models attempted to identify risk factors for time to distant brain failure (DBF) or time to salvage whole-brain radiation therapy (WBRT) to predict the benefit …
H Mehrabian, J Detsky, H Soliman, A Sahgal… - Frontiers in …, 2019 - frontiersin.org
Brain metastases are the most common intracranial tumors and occur in 20–40% of all cancer patients. Lung cancer, breast cancer, and melanoma are the most frequent primary …
M Abdulhaleem, H Johnston, R D'Agostino Jr… - Journal of Neuro …, 2022 - Springer
Background Previous series have demonstrated CNS activity for immune checkpoint inhibitors, yet no prior data exists regarding whether this activity can improve outcomes of …
Abstract Purpose Gamma Knife radiosurgery (GKRS) is a non-invasive procedure for the treatment of brain metastases. This study sought to determine whether radiomic features of …
J Su, Q Song, S Qasem, S O'Neill, J Lee… - Frontiers in …, 2021 - frontiersin.org
Background The incidence of brain metastasis continues to increase as therapeutic strategies have improved for a number of solid tumors. The presence of brain metastasis is …
C Nieder, MP Mehta, H Geinitz, AL Grosu - Critical reviews in oncology …, 2018 - Elsevier
Objective To review published nomograms that predict endpoints such as overall survival (OS) or risk of intracranial relapse in patients with brain metastases from solid tumors …